6533b836fe1ef96bd12a195c

RESEARCH PRODUCT

Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation

Sabrina RealmutoGiuseppe SalemiPaolo RagoneseMarianna Lo ReVincenzina Lo ReMaria Antonietta MazzolaGiovanni Savettieri

subject

Settore MED/26 - NeurologiaMultiple sclerosis natalizumab therapyhttp://hdl.handle.net/10447/72820